Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Genital Diseases, Female
>>
RET inhib
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
sorafenib
/ Generic mfg.
sunitinib
/ Generic mfg.
Caprelsa
(vandetanib) / Sanofi
Lenvima
(lenvatinib) / Eisai, Merck (MSD)
motesanib
(AMG 706) / Takeda
